Meiko Trans Co., Ltd. (XNGO:9357)
Japan · Delayed Price · Currency is JPY 1,981.00
+5.00 (0.25%)
At close: Aug 8, 2025
Inozyme Pharma Revenue
Meiko Trans had revenue of 20.39B JPY in the quarter ending June 30, 2025, with 5.24% growth. This brings the company's revenue in the last twelve months to 82.50B, up 5.75% year-over-year. In the fiscal year ending March 31, 2025, Meiko Trans had annual revenue of 81.49B with 4.87% growth.
Revenue (ttm)
82.50B
Revenue Growth
+5.75%
P/S Ratio
0.72
Revenue / Employee
43.54M
Employees
1,895
Market Cap
59.24B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 81.49B | 3.79B | 4.87% |
| Mar 31, 2024 | 77.70B | -6.40B | -7.61% |
| Mar 31, 2023 | 84.10B | 2.83B | 3.48% |
| Mar 31, 2022 | 81.27B | 14.22B | 21.21% |
| Mar 31, 2021 | 67.05B | -3.85B | -5.43% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Toyota Motor | 48.45T |
| Mitsubishi UFJ Financial Group | 5,440.78B |
| Sony Group | 13.01T |
| SoftBank Group | 7,362.35B |
| Hitachi | 9,830.27B |
| Nintendo | 1,490.65B |
| Sumitomo Mitsui Financial Group | 3,346.44B |
| Fast Retailing | 3,354.04B |